Activation of NF-κB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 21, 2003, Pages 12408-12413

  Taddeo, Brunella ^a   Luo, Ting Rong ^a,b   Zhang, Weiran ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b GUANGXI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE; PROTEIN KINASE R; PROTEIN PHOSPHATASE 1ALPHA; UNCLASSIFIED DRUG; CHUK PROTEIN, MOUSE; I KAPPA B; I KAPPA B KINASE; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, MOUSE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEIN SERINE THREONINE KINASE;

ALPHA CHAIN; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; GENE TRANSLOCATION; GENE US11; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; UPREGULATION; VIRUS GENE; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CYTOPLASM; GENE DELETION; GENETICS; HERPES SIMPLEX; METABOLISM; MOUSE; MUTATION; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

DNA VIRUSES; EUKARYOTA; HUMAN HERPESVIRUS 1; MURINAE; SIMPLEXVIRUS;

ANIMALS; APOPTOSIS; CELL LINE; CYTOPLASM; EIF-2 KINASE; ENZYME ACTIVATION; GENE DELETION; GENES, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; I-KAPPA B KINASE; I-KAPPA B PROTEINS; MICE; MODELS, BIOLOGICAL; MUTATION; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES;

EID: 0142027749     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.2034952100     Document Type: Article

References (27)

1. Taddeo, B., Esclatine, A. & Roizman, B. (2002) Proc. Natl. Acad. Sci. USA 99, 17031-17036.
2. Patel, A., Hanson, J., McLean, T. I., Olgiate, J., Hilton, M., Miller, W. E. & Bachenhiemer, S. L. (1998) Virology 247, 212-222.
3. Amici, C., Belardo, G., Rossi, A. & Santoro, M. G. (2001) J. Biol. Chem. 276, 28759-28766.
4. Taddeo, B., Esclatine, A., Zhang, W. & Roizman, B. (2003) J. Virol. 77, 6178-6187.
5. Pahl, H. L. (1999) Oncogene 18, 6853-6866.
6. Ghosh, S. & Karin, M. (2002) Cell 109, S81-S96.
7. Hiscott, J., Kwon, H. & Genin, P. (2001) J. Clin. Invest. 107, 143-151.
8. Zamanian-Daryoush, M., Mogensen, T. H., DiDonato, J. A. & Williams, B. R. G. (2000) Mol. Cell. Biol. 20, 1278-1290.
9. Kozac, M. & Roizman, B. (1975) J. Virol. 15, 36-40.
10. Jacquemont, B. & Roizman, B. (1975) J. Virol. 15, 707-713.
11. Mohr, I. & Gluzman, Y. (1996) EMBO J. 15, 4759-4766.
12. He, B., Chou, J., Brandimarti, R., Mohr, I., Gluzman, Y. & Roizman, B. (1997) J. Virol. 71, 6049-6054.
13. Cassady, K. A., Gross, M. & Roizman, B. (1998) J. Virol. 72, 7005-7011.
14. Roller, R. J. & Roizman, B. (1990) J. Virol. 64, 3463-3470.
15. Sciortino, M. T., Taddeo, B., Poon, A. P. W., Mastino, A. & Roizman, B. (2002) Proc. Natl. Acad. Sci. USA 99, 8318-8323.
16. Cassady, K. A., Gross, M. & Roizman, B. (1998) J. Virol. 72, 8620-8626.
17. Ejercito, P. M., Kieff, E. D. & Roizman, B. (1968) J. Gen. Virol. 2, 357-364.
18. Soliman, T. M., Sandri-Goldin, R. M. & Silverstein, S. J. (1997) J. Virol. 71, 9188-9197.
19. DeLuca, N. A., McCarthy, A. & Schaffer, P. A. (1985) J. Virol. 56, 558-570.
20. Poon, A. P. W. & Roizman, B. (1997) Virology 229, 98-105.
21. Longnecker, R. & Roizman, B. (1986) J. Virol. 65, 583-591.
22. Roller, R. J. & Roizman, B. (1992) J. Virol. 66, 3624-3632.
23. Ackermann, M., Braun, D. K., Pereira, L. & Roizman, B. (1984) J. Virol. 52, 108-118.
24. Zamanian-Daryoush, M., Der, S. D. & Williams, B. R. G. (1999) Oncogene 18, 315-326.
25. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E. & Karin, M. (1997) Nature 388, 548-554.
26. Goodkin, M. L., Ting, A. T. & Blaho, J. A. (2003) J. Virol. 77, 7261-7280.
27. Chou, J., Chen, J. J., Gross, M. & Roizman, B. (1995) Proc. Natl. Acad. Sci. USA 92, 10516-10520.